Sonogen Medical

Executive Summary

Sonogen Medical is a pre-clinical stage medical device company developing a novel acoustic shear wave technology to accelerate bone fracture healing. Founded in 2018 and based in San Diego, the company leverages decades of scientific research demonstrating the biomechanical effects of acoustic shear waves at the cellular level. Its patent-pending signal is specifically designed to optimize bone healing, addressing a significant unmet need in orthopedics. While still in early development and without disclosed funding or valuation, the technology has potential for wide applicability. The company is currently focused on advancing its platform through pre-clinical studies and preparing for regulatory discussions. Sonogen represents a high-risk, high-reward opportunity in the medical devices space, with conviction tempered by its early stage and lack of public data.

Upcoming Catalysts (preview)

• Q1 2027Completion of Pre-Clinical Efficacy Study60% success
• Q2 2027Series A Funding Round50% success
• Q3 2027Pre-IND Meeting with FDA70% success